25 results
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
to the Section 16(a) filing requirements during the year ended December 31, 2023.
Policy Prohibiting Hedging and Pledging
Pursuant to our Insider Trading … Policy, our officers, directors, and employees are prohibited from engaging in speculative trading, including hedging transactions or short sale
10-K
2023 FY
EX-19.1
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
the heading “Prohibited Types of Transactions,” including among others short sales and hedging transactions, may not be carried out through a Trading Plan … securities, on an exchange or in any other organised market, are prohibited by this Policy. (Option positions arising from certain types of hedging
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
of operations and cash flows from period to period. Currently, we do not have any exchange rate hedging arrangements in place.
The U.K.’s withdrawal … -balance sheet risk or concentration of credit risk, such as foreign exchange contracts, options contracts, or other foreign hedging arrangements
6-K
EX-99.2
MREO
Mereo Biopharma Group Plc
28 Oct 22
Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management
7:11am
of the Company:
(i) acquire, seek or propose (publicly or otherwise) to acquire, directly or indirectly, through swap or hedging transactions or otherwise … or hedging transactions or otherwise, any securities of the Company or any rights decoupled from the underlying securities of the Company held
F-3/A
ltvo3dbghkl7u
27 Sep 21
Shelf registration (foreign) (amended)
4:18pm
F-3/A
xxlz5quuhr0a6cic9
7 Sep 21
Shelf registration (foreign) (amended)
4:06pm
F-3
padrlxt7jw2ta3
5 Aug 21
Shelf registration (foreign)
4:33pm
424B5
aufu4irygguy77obeh50
10 Feb 21
Prospectus supplement for primary offering
4:53pm
424B5
tvwkyikkee0wwnnrhbk
9 Feb 21
Prospectus supplement for primary offering
5:24pm
F-3
4027f8 ksq
6 Jul 20
Shelf registration (foreign)
4:58pm
POS AM
4vzpinjdich ybllv
2 Jul 20
Prospectus update (post-effective amendment)
3:57pm
6-K
EX-10.1
el3b9rqtuwfvvqm
5 Jun 20
Mereo BioPharma Announces Completion of $70 Million Private Placement
12:00am
F-1/A
lrgy69
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
6drzbw2mw5s7rbe
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
6-K
EX-10.1
br75swwf9tqf2i64sotj
19 Feb 20
Mereo BioPharma Announces Equity Investment of $3 Million from New U.S. Institutional Investor
9:32am
F-1
bsbzahk1 cwml3r
18 Feb 20
Registration statement (foreign)
5:15pm
6-K
EX-10.1
c0bdn
10 Feb 20
Current report (foreign)
7:20am